OIA
KRBP

OneDigital Investment Advisors’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

OneDigital Investment Advisors’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-333
Closed -$31K – 837
2021
Q3 		$31K Buy
+333
New +$34.5K ﹤0.01% 744

Other funds holding KRBP

KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OneDigital Investment Advisors's KRBP Position: Q4 2021 in Review

OneDigital Investment Advisors sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q4 2021, closing a stake of 333 shares — an estimated $31K sold.

OneDigital Investment Advisors first reported a position in KRBP in Q3 2021 and held it in 1 quarter. The position peaked at $31K in Q3 2021. 20 funds tracked by Wall St. Rank hold KRBP as of Q4 2021.

  • OneDigital Investment Advisors reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • OneDigital Investment Advisors sold 333 Kiromic BioPharma, Inc. Common Stock shares in Q4 2021, an estimated $31K.
  • OneDigital Investment Advisors first reported a position in Kiromic BioPharma, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • OneDigital Investment Advisors's Kiromic BioPharma, Inc. Common Stock position peaked at $31K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q4 2021.

Based on OneDigital Investment Advisors's 13F filing for Q4 2021, filed 23 Feb 2022.